Renaissance Capital logo

EUDA Health (8i Acquisition 2) Priced, Nasdaq: EUDA

Second Asia-focused blank check company backed by 8i Capital (completed 11/17/2022).

Industry: SPAC

Latest Trade: $4.50 0.00 (0.0%)

First Day Return: +1.2%

Return from IPO: -55.0%

Industry: SPAC

We are a blank check company incorporated in the British Virgin Islands on January 21, 2021 as a business company limited by shares (meaning that our public shareholders have no liability, as shareholders of our company, for the liabilities of our company over and above the amount paid for their shares). We were formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, which we refer to as a “target business.” Our efforts to identify a prospective target business will not be limited to a particular industry or geographic location, although we currently intend to focus on opportunities in Asia. We do not have any specific business combination under consideration and we have not (nor has anyone on our behalf), directly or indirectly, contacted any prospective target business or had any substantive discussions, formal or otherwise, with respect to such a transaction. Additionally, we have not engaged or retained any agent or other representative to identify or locate any suitable acquisition candidate, to conduct any research or take any measures, directly or indirectly, to locate or contact a target business.
more less
IPO Data
IPO File Date 05/25/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 7.5
Deal Size ($mm) $75
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 11/22/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 7.5
Deal Size ($mm) $75
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Maxim Group LLC
Company Data
Headquarters Singapore, Singapore
Founded 2021
Employees at IPO 2
Website www.8icorp.com

EUDA Health (8i Acquisition 2) (EUDA) Performance